Some Batches of Children’s Panadol Recalled Over Contamination Fears

The Health Department has issued a recall on Children’s Panadol warning that some batches were contaminated with invisible fibres that could prompt allergic reactions.

Its manufacturer GlaxoSmithKline Consumer Healthcare Australia urged for the recall from pharmacies and wholesalers.

In a recall alert released on Thursday, the Health Department, in consultation with the Therapeutic Goods Administration, has made a recall on three batches of Children’s Panadol, five-to-12 years suspension in 200 millilitre bottles, which has an expiry date of February 2018.

The batch number and expiry date are located at the bottom of the bottle label and on the base of the packaging.

The affected batches are:

• 136418 (strawberry flavour)
• 136444 (strawberry flavour)
• 136443 (orange flavour)

The TGA said in its advisory: “It has been identified that an ingredient used in the manufacture of these medicines may have been contaminated with small particles that could contain trace minerals and inert fibres.”

The TGA added that the quantity of the said particles may be so small that these may not be visible in the product.

“If this occurs, there is a very low risk of allergic reaction and there is also potential for the medicine to be less effective over time.”

The TGA has also advised that the affected product could be returned to the place of purchase for a refund.

No other batches, bottle sizes or products are affected by this recall.

Anyone with concerns may call GlaxoSmithKline Consumer Healthcare Australia through 1800 028 533.

Source: Abc.net.au and Smh.com.au